Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
»
companies
» Anthera Pharmaceuticals
Anthera Pharmaceuticals
Key FDA Decisions and Trial Results Expected in October
Key FDA Decisions and Trial Results Expected in October
24/7 Wall St
FDA
clinical trials
Exelixis
cabozantinib
Cobimetinib
Celldex Therapeutics
CDX-011
Cerulean Pharma
CRLX101
Medivation
Xtandi
Palatin
bermelanotide
Rexahn
RX-3117
Anthera Pharmaceuticals
Flag link:
Key FDA Decisions and Trial Results Expected in October
Key FDA Decisions and Trial Results Expected in October
24/7 Wall St
FDA
clinical trials
cabozantinib
Cobimetinib
Exelixis
Medivation
Xtandi
Celldex Therapeutics
glemba
Palatin
bremelanotide
CRLX101
Cerulean Pharma
Anthera Pharmaceuticals
Flag link:
In The Sea Of Biotechs, Anthera's Multi-Drug Pipeline Makes It Attractive
In The Sea Of Biotechs, Anthera's Multi-Drug Pipeline Makes It Attractive
Yahoo/Benzinga
Anthera Pharmaceuticals
cystic fibrosis
Flag link:
Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update
Anthera Pharmaceuticals Reports 2014 Third Quarter Financial Results and Operational Update
Yahoo/PR NewsWire
Anthera Pharmaceuticals
earnings
Flag link:
